511 filings
Page 5 of 26
8-K
cq5q6y 9xqul5wqja
30 Sep 21
Catalyst Pharmaceuticals Receives Positive Decision from Appeals Court That Supports Orphan Drug Exclusivity for FirdapseĀ® for LEMS
5:13pm
8-K
ibbj7
16 Aug 21
Other Events
12:00am
8-K
zedaf3sp qiln
9 Aug 21
Catalyst Pharmaceuticals Announces Second Quarter 2021 Financial Results and Provides Corporate Update
5:28pm
8-K
m4i4 zuobg
19 Jul 21
Catalyst Pharmaceuticals Announces Issuance of U.S. Patent 11,060,128 a
4:21pm
8-K
y8ca0 dszn0e5e5ab7an
6 Jul 21
Catalyst Pharmaceuticals Expands Leadership Team with Appointment of Preethi Sundaram, Ph.D. as Chief Product Development Officer
8:15am
8-K
5rvxbwxbs olofvg5k5
30 Jun 21
Entry into a Material Definitive Agreement
4:30pm
8-K
nnkuj9h1ir6vc ua
29 Jun 21
Catalyst Pharmaceuticals Appoints Pharmaceutical Executive Molly Harper to its Board of Directors
8:22am
8-K
hzu363lku1l
28 Jun 21
Other Events
5:02pm
8-K
tzg5vonn
3 Jun 21
Other Events
5:06pm
8-K
e5292 gfqvx
11 May 21
Catalyst Pharmaceuticals Announces First Quarter 2021 Financial Results and Provides Business Update
12:00am
8-K
99nbmsqtppyza
22 Mar 21
Catalyst Pharmaceuticals Announces $40 Million Share Repurchase Program
8:35am
8-K
fr3 dx6b75hm
16 Mar 21
Catalyst Pharmaceuticals Announces Fourth Quarter and Year-End 2020 Financial Results and Provides Corporate Update
8:11am
8-K
v59v5c2
6 Jan 21
Catalyst Pharmaceuticals Announces Strategic Plan for Product Portfolio Expansion for Long-Term Success and Provides Corporate Update
4:28pm
8-K
trp86fcnln9h2r81
10 Nov 20
Catalyst Pharmaceuticals Announces Third Quarter 2020 Financial Results and Provides Business Update
12:00am